HUTCHMED (China) (HCM) Non Operating Income (2018 - 2021)
HUTCHMED (China)'s (HCM) quarterly Non Operating Income came in at $3.0 million in Q2 2021, up 624.94% year-on-year from $413000.0 in Q2 2020, and up 921.84% on a QoQ basis from $293000.0 in Q1 2021.
HUTCHMED (China) (HCM) Non Operating Income (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has 4 years of Non Operating Income data on file, last reported at $3.0 million in Q2 2021.
- On a quarterly basis, Non Operating Income rose 624.94% year-over-year to $3.0 million in Q2 2021; TTM through Jun 2021 was $4.9 million, a 54.37% increase from a year earlier, with the FY2025 full-year figure at $61.0 million, up 43.09% from the prior year.
- Non Operating Income for Q2 2021 stood at $3.0 million, up from $293000.0 in the prior quarter.
- Over the last five years, Non Operating Income for HCM reached as high as $3.0 million in Q2 2021 and fell as low as -$31000.0 in Q4 2019.
- Historically, Non Operating Income has averaged $1.3 million across 4 years, with a median of $1.2 million in 2018.
- Across the five-year window, Non Operating Income plunged 102.8% in 2019 and surged 624.94% in 2021, its largest moves.
- Year by year, Non Operating Income stood at $1.1 million in 2018, then plunged by 102.8% to -$31000.0 in 2019, then surged by 1432.26% to $413000.0 in 2020, then jumped by 624.94% to $3.0 million in 2021.
- Per Business Quant data, the three most recent Non Operating Income figures were $3.0 million in Q2 2021, $293000.0 in Q1 2021, and $413000.0 in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | -7.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | HUTCHMED (China) | 9.45 Bn | 9.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 2.99 Mn |
| Mar 31, 2021 | 293,000.00 |
| Jun 30, 2020 | 413,000.00 |
| Mar 31, 2020 | 1.17 Mn |
| Dec 31, 2019 | -31,000.00 |
| Sep 30, 2019 | 1.60 Mn |
| Jun 30, 2019 | 2.57 Mn |
| Mar 31, 2019 | 1.14 Mn |
| Dec 31, 2018 | 1.11 Mn |
| Sep 30, 2018 | 1.69 Mn |
| Jun 30, 2018 | 2.04 Mn |
| Mar 31, 2018 | 1.15 Mn |